If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
8
Followers on Owler
Numab
is a Switzerland-based biotechnology company that discovers and develops immuno-oncology therapies for the treatment of cancer...
Read more
Overview
Competitors
Funding
News & Insights
Numab
is a Switzerland-based biotechnology company that discovers and develops immuno-oncology therapies for the treatment of cancer...
Read more
Co-Founder & CEO
David Urech
CEO Approval Rating
89/100
Weigh In
2011
Horgen
Zurich
Private
Pharmaceuticals & Biotechnology
Biotechnology
2834
NAICS listing
https://numab.com/
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$204M
News
Key Events
Latest News
Partnership
Apr 15, 2025
Marketscreener
Physiomics extends long-term collaboration with Numab via new contract
Funding
Jan 09, 2025
GlobalNewswire
Numab received $55M in Series C Funding
Follow and Get Alerts
Numab Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 15 + competitors
Trending Companies
